Fractionated ionising radiation affects cellular functions, and gene expression associated to subpopulation of F11 dorsal root ganglia neurons without inducing oxidative stress

Cancer treatment often relies on powerful beams of energy to destroy malignant cells, a practice known as radiotherapy. While this approach is highly effective at stopping the growth of tumors, it can leave behind a lingering shadow for survivors: chronic pain that persists long after the cancer itself has been cured. To understand why this happens, scientists look to the body's sensory network, specifically the dorsal root ganglia. These are small clusters of nerve cells located just outside the spinal cord that act as relay stations, carrying signals about touch, temperature, and pain from the skin and muscles to the brain. When these nerves are damaged or altered, the brain may receive incorrect or heightened signals, resulting in the sensation of pain without any current injury. Understanding how medical treatments affect these specific nerve cells is crucial for finding ways to prevent this long-term suffering.

Researchers set out to investigate exactly how radiation exposure changes the behavior of these sensory neurons. They used a laboratory model of rat nerve cells, known as the F11 cell line, to simulate what happens when the body receives a standard course of radiotherapy. Instead of a single blast of energy, the cells were exposed to ionizing X-rays over four consecutive days, with a dose of 5 Gy each day, bringing the total exposure to 20 Gy. This method mimics the fractionated treatment schedule patients receive in the clinic, where the total dose is split into smaller parts to spare healthy tissue. On the fifth day, one day after the final exposure, the scientists examined the cells to see what had changed. They checked for signs of cellular aging, known as senescence, looked for evidence of oxidative stress which is a type of cellular damage caused by unstable molecules, and measured how the cells were using energy and managing their mitochondria, the tiny power plants inside every cell. They also assessed the expression of genes associated with subpopulations of DRG neuronal fibres.

The investigation revealed a clear picture of how these nerve cells respond to radiation. The cells showed an increase in senescence, meaning they had entered a state where they stop dividing but remain alive and active. The number of mitochondrial copies within the cells also rose, and the balance of energy-carrying molecules shifted, indicating a change in how the cells manage their internal fuel. However, contrary to what might be expected, the radiation did not trigger oxidative stress in the cells twenty-four hours after the last dose, nor did it alter the rate at which the cells consumed oxygen. This finding is significant because it suggests that the pain associated with radiotherapy might not stem from the immediate, chaotic damage of free radicals, but rather from more subtle, long-term shifts in how the nerve cells function and age.

Perhaps most importantly, the study found that the radiation changed the genetic instructions within these nerve cells. Specifically, ionising radiation altered the expression of genes associated with mechanoreceptor fibres. These are the specific nerve fibers responsible for sensing mechanical pressure and touch, which are also known to play a role in amplifying pain signals when the body is injured. The fact that radiation changed the activity of these particular genes suggests a direct link between the treatment and the development of chronic pain. The cells did not simply die or become generally damaged; instead, they underwent a specific reprogramming that could make them more sensitive to pain signals. This discovery points toward a mechanism where the treatment itself quietly rewires the sensory nerves, potentially explaining why some cancer survivors experience persistent pain long after their therapy has ended.